Stop TB Partnership

Open Letter to the WHO to put #TBontheList

TB Community Demands WHO to include #TBontheList!

Thank you for your support!

Geneva, Switzerland - 6 March 2017 -- We would like to thank you for your signatures, endorsements and support!

Today, we delivered the letter to WHO Director-General Dr Margaret Chan requesting inclusion of mycobacterium tuberculosis in the WHO's Global Priority List of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics.

This letter was signed so far by 40 of the leading institutions working in TB and Global Health as well as 261 individuals representing researchers, scientists, civil society and communities, clinicians, health workers, advocates and heads of agencies from all around the world.

TB People - the Eastern European and Central Asian Network of people with experience of TB - also delivered a letter today to WHO signed by 400 TB advocates.

These are in addition to the letters submitted by several partners and networks, such as The UNION, the TB Alliance and Global Coalition of TB Activists.

This is just the beginning of our campaign and we will not stop until we have the Global Priority List of antibiotic-resistant bacteria revised and mycobacterium tuberulosis included in it.

Let's keep the momentum and the incredible unity created among all of us to further pursue our agenda in ensuring TB is recognized and addressed as a global health threat, a security threat, a driver of anti-microbial resistance globally and a disease in incredible need of proper research and development attention and resources.

We are all in this, lets do it!

Dr Margaret Chan
Director General
World Health Organization
Avenue Appia 20
1211 Geneva 27

cc: ADG Ren
ADG Kieny
ADG Inoue

6 March 2017

Global TB community demands inclusion of mycobacterium tuberculosis in the WHO’s Global Priority List of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics.

Dear Dr Chan, Dr Ren, Dr Kieny and Dr Inoue,

We are writing to you collectively as the representatives of the global TB community to express our deepest concerns about the exclusion of Mycobacterium tuberculosis within WHO’s first-ever ‘global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics’, published on 27 February 2017.

While the list is a great initiative to guide us towards a world without resistance to antibiotics, it is outrageous that Mycobacterium tuberculosis was left out of consideration, for the reason that ‘it is already a globally established priority’. In other words, TB was not considered for inclusion in a global priority list, because it is evidently a global priority. This explanation defies reason.

TB’s exclusion sends the false and counterproductive message that drug-resistant TB is not a public health threat. As we are well aware, TB is the world’s leading infectious disease killer and drug-resistant TB is responsible for one-third of all AMR deaths. It also provides the wrong impression that funding for TB R&D has been secured, though we know that the TB R&D funding available represents barely 30% of the needs and has been declining for the least three years.

Dr. Chan, we acknowledge and thank you for the statement on 28 February in which you clearly highlighted that "Addressing drug-resistant TB research is a top priority for WHO and for the world".

However, we, the undersigned individuals and organizations, demand that you show strong leadership by facilitating the timely review of the Global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics in order to include mycobacterium tuberculosis on it.

This review should be conducted without any further delay to include its findings within the ‘full protocol and results’ to be published on the WHO website no later than end of May 2017.



  1. ACTION global health advocacy partnership
  2. Aequitas Consulting Pvt. Ltd
  3. Afghan Community Research & Empowerment Organization for Development (ACREOD), Kabul, Afghanistan
  4. Alliance for Public Health, Kyiv, Ukraine
  5. AMAL (Aide médicale en Amérique Latine), Paris, France
  6. Bridget and Hendrik Brand, South Africa
  7. Burnet Institute
  8. Centre for the Development of People, Malawi
  9. Damien Foundation, Netrakona TB & Leprosy Control Project
  10. Desmond Tutu HIV Foundation (DTHF)
  11. Desmond Tutu HIV Centre (DTHC)
  12. DR-TB Scale Up Treatment Action Team (DR-TB STAT)
  13. EMPOWER INDIA, India
  14. Global Health Advocates (GHA), France
  15. Global Health Advocates India
  16. Global TB Community Advisory Board (TB CAB)
  17. Hospice Palliative Care Association of South Africa, South Africa
  18. Instituto de Salud y Derechos Humanos, Peru
  19. International HIV/AIDS Alliance
  20. KNCV
  21. KNP+
  22. MANGO Key Populations NGO Network, Malawi
  23. Maphunziro Foundation, Malawi
  24. National Empowerment Network of PLHIV in Kenya - NEPHAK, Nairobi, Kenya
  25. National TB Controllers Association, USA
  26. REACH (The Resource Group for Education and Advocacy for Community Health), India
  27. RESIST-TB (Research Excellence to Stop TB Resistance)
  28. RESULTS Canada
  29. RESULTS International, Australia
  32. SECTION27, South Africa
  33. Spotlight, South Africa
  34. Southern African Medical Unit, Médecins Sans Frontières / Doctors Without Borders Southern Africa
  35. The Stop TB Partnership
  36. Stop TB USA
  37. Treatment Action Group, New York, USA
  38. TB Alliance
  39. TB Europe Coalition
  40. TB Photovoice
  41. TB Proof
  42. Treatment Action Campaign
  43. The Union
  45. Worldwide Hospice Palliative Care Alliance


  1. Timur Abdullaev, Interim Steering Committee member, TBpeople, Uzbekistan
  2. Anu Acharya, CEO Mapmygenome India
  3. Lisa V. Adams, MD, Secretary/Treasurer of The TB Union NAR, Geisel School of Medicine at Dartmouth, USA
  4. Ize Adava, HIV Network , Nigeria
  5. Dr. Kulsoom Akhtar, Chairperson, Active Help Organization (AHO) (R) NGO, Lahore, Pakistan
  6. Chibuike Amaechi - The Good Neighbour, Lagos. Nigeria
  7. Dr. Farhana Amanullah, Chair- Child and Adolescent TB Working Group, DABP, Pediatrician, The Indus Hospital Pakistan, Pakistan
  8. MD Emmanuel Andre, Deputy Head of Laboratory, Cliniques Universitaires Saint-Luc, Belgium
  9. Mercy Annapoorni, India GCTA Board Member - Asia Pacific
  10. Lusiana Aprilawati, TB advocacte, Indonesia TB Care Network
  11. Uliane Appolinario, Brazil
  12. Austin Arinze Obiefuna, Afro Global Alliance, Ghana
  13. Dr. Wouter Arrazola de Oñate, Medical director BELTA , Belgian Lung and Tuberculosis Association, Belgium
  14. Samuel Boateng Arthur, Executive Director, Clikgold Association
  15. Rusudan Aspindzelashvili, Head of Laboratory, NCTLD, Georgia
  16. Happy Assan, TANPUD (PWUD - KP), Tanzania
  17. Berhanemeskal Assefa, Principal Technical Advisor, TB Health Programs Group, Management Sciences for Health, Ethiopia
  18. Iyamuremye Athanase, Hope for living youth who use drugs, Rwanda
  19. Aung, Damien Foundation Bangladesh
  20. Zaza Avaliani, Director of the National Center for Tuberculosis and Lung Diseases (NCTLD), Georgia
  21. Dr. Wouter Arrazola de Oñate, Medical director BELTA , Belgian Lung and Tuberculosis Association, Belgium
  22. Jean Pierre Ayingoma, RBC, Rwanda
  23. Carlos Basilia, Secretário Ejecutivo, Stop TB Brasil, Brazil
  24. Anton Basenko, International Network of People who Use Drugs, Eurasian Network of People who Use Drugs
  25. Dr Mairi Bassingthwaighte, Paediatric Oncology Fellow, Chris Hani Baragwanath Hospital, Johannesburg, South Africa
  26. Prof Linda-Gail Bekker (President of the International AIDS Society, Deputy Director of the DTHC, and Chief Operating officer of the DTHF)
  27. Dr. Marcel Behr, Microbiologist-in-Chief, McGill University Health Centre, Montreal, Canada
  28. Robert Benjamin,MD, MPH, Independent Consultant, Global and Domestic Public Health, California, USA
  29. Mauha Berry, AFRIYAN - YOUTH, Namibia
  30. Chris Beyrer, Professor, Department of Epidemiology, Bloomberg School of Public Health, The Johns Hopkins University, USA
  31. Samuel Boateng Arthur, Executive Director, Clikgold Association & Regional Chairman, GAR, Coalition of NGOs in Health & Coordinator, Otumfuo Royal Diary Project, Manhyia, Kumasi
  32. Dr.Catharina Boehme, Co-Chair, New Diagnostics Working Group
  33. Sr. Ángel Bolaños Flores, Presidente de la Asociación Indígena Aymara "Suma Qamañataki" (Por un buen vivir), Arica, Región de Arica y Parinacota, Chile
  34. Pat Bond, Occupational MDR-TB survivor, Professional Nurse, TB Proof, South Africa
  35. Dr. Grania Brigden, 3P Project Lead, The Union
  36. Miranda Brouwer, independant TB consultant at PHTB Consult, Tilburg, The Netherlands
  37. James C.M. Brust, MD, Associate Professor of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA
  38. David Bryden, TB Advocacy Officer, RESULTS USA, USA
  39. Barbara Bulc, President, Global Development, Geneva, Switzerland
  40. Joseph Burzynski, MD, MPH, Director, Bureau of TB Control, New York City DOHMH, USA
  41. Rufino Campos, President of the Board of Directors, Asociación Nacional de Personas Viviendo con VIH/SIDA en Honduras (ASONAPVSIDAH), San Pedro Sula, Honduras
  42. Prof. Jane Carter, M.D., Immediate Past President of The Union, Brown University School of Medicine, USA
  43. José Luis Castro, Executive Director, The Union
  44. Roy Chan, President, Action for AIDS, Singapore
  45. Jeremiah Chakaya, President, International Union Against Tuberculosis and Lung Disease ( The UNION); Chief Executive Officer/Technical Lead, Kenya Association for the Prevention of Tuberculosis and Lung Disease ( KAPTLD) and Kenya Thoracic Society; Chair, Stop TB Partnership Kenya
  46. Joan Chamungu, TNW+, Tanzania
  47. Choub Sok Chamreun, KHANA, Cambodia
  48. Angelina Chiwateni, Women’s sector PLHIV, Zimbabwe
  49. Kennedy P. Chungu, Programs Officer, Zambia Network of Religious Leaders Living with or Personally Affected by HIV and AIDS ZANERELA+
  50. Dr Daniela Cirillo, Co-Chair, New Diagnostics Working Group
  51. Brian Citro, Clinical Lecture in Law, University of Chicago Law School, Chicago, USA
  52. Clemence Clara, TCEF/ Trans/KP, Tanzania
  53. Alberto Colorado, Americas TB Coalition
  54. Luc Comhaire, Project Manager, Damien Foundation, Belgium
  55. Peter Cooper, Professor Emeritus, Department of Paediatrics & Child Health, University of the Witwatersrand, South Africa
  56. Professor Ashraf Coovadia - Head of Paediatrics and Child Health, University of the Witwatersrand and Director of the Empilweni Services and Research Unit (ERSU), Johannesburg, South Africa
  57. Prof. Helen Cox, Division of Medical Microbiology, Department of Pathology, University of Cape Town, South Africa
  58. Prof. Luis E. Cuevas, Head of the Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
  59. Manfred Danilovits, TB consultant, Tartu University Hospital, Estonia
  60. Daniel G. Datiko, REACH Ethiopia, Hawassa, Ethiopia
  61. Dr Angela de Sá, Family Physician & Division of Family Medicine, University of Cape Town, South Africa
  62. Rebecca Decker, Program Director, GOLD and GINA, Global Initiative for Chronic Obstructive Lung Disease, Global Initiative for Asthma
  63. Dr. Tine Demeulenaere, Medical Advisor, Damien Foundation, Belgium
  64. Dr. Lucica Ditiu, Executive Director, Stop TB Partnership, Geneva, Switzerland
  65. Anna (Ganna) Dovbakh, Acting Executive Director, Eurasian Harm Reduction Network (EHRN), Vilnius, Lithuania
  66. Dr. Jenny Durandt, Family doctor, Cape Town, South Africa
  67. Sergii Dvoriak, Head of the Board, Ukrainian Institute on Public Health Policy (UIPHP), Ukraine
  68. Dr. Osman El tayeb, Damien Foundation Representative & Medical Advisor
  69. Maura Elaripe, Papua New Guinea
  70. Kathy Eridania Brito De Guzman, GCTA Board Member- Latin America
  71. Emmanual Etim, CISPHA - Youth, Ethiopia
  72. Dr Syed Fasihuddin, Chest Consultant and CEO, Tabeer (NGO) and Taj Clinics
  73. Endalkachew Fekadu, Volunteer Health Services (VHS), Ethiopia
  74. Thomas Ferkol, MD, Professor Of Pediatrics, Washington University, Past president American Thoracic Society Cell Biology And Physiology, Washington, USA
  75. Fogué Foguito, Executive Director, Positive-Generation
  76. Jennifer Furin, MD., PhD., Senior Lecturer, Harvard Medical School, Department of Global Health and Social Medicine, USA
  77. Dr. Shalva Gamtsemlidze, Tuberculosis Specialist, Tbilisi, Georgia
  78. Dr. Alberto Garcia-Basteiro, M.D., Centro de Investigacion em Saude de Manhiña, Mozambique
  79. Ms Elise Garises, Ministry of Mines and Energy, Namibia
  80. Lucy Ghati, KELIN-Kenya, Kenya
  81. Nana Gleeson, BONELA, Botswana
  82. Liz Gwyther, palliative care physician, University of Cape Town, South Africa
  83. Charity H. Habeenzu, CEO, Zambia Tuberculosis and Leprosy Trust (ZATULET)
  84. James Hakim, Professor of Medicine, The University of Zimbabwe College of Health Scienc-es, Zimbabwe
  85. Ida Hakizinka, Executive Director, Aidspan, Nairobi, Kenya
  86. Ha Hang Pham, Senior Program Manager, Friends for International TB Relief, Ho Chi Minh City, Viet Nam
  87. Marion Heap, PhD, Health and Human Rights Programme, School of Public Health and Family Medicine, University of Cape Town, South Africa
  88. Prof. Sabine Hermans, assistant professor, MD, MSc, Phd, Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands
  89. Anneke C. Hesseling, Director, Desmond Tutu TB Centre
  90. Mark Heywood
  91. Dr. Abukar Ali Hilowle, NTP manager MOH-FG, Somalia
  92. Du Hoang Ha, The head of ACSM - VSTP Group of Vietnam National Tuberculosis Control Program (NTP), Ha Noi, Vietnam
  93. Olivia Horna Campos, PhD, Profesor Asistente, División de epidemiología, Escuela de Salud Pública, Facultad de Medicina, Universidad de Chile
  94. C. Robert Horsburgh, Jr., MD, MUS, Chair, RESIST-TB Steering Committee, Professor of Epidemiology, Biostatistics and Medicine, Boston University
  95. Sophie Huddart, MSc, McGill University, Montreal, Canada
  96. Jennifer Hughes, DR-TB doctor, Médecins Sans Frontières (MSF) Khayelitsha
  97. Dr Petros Isaakidis, Operational Research Coordinator, Médecins Sans Frontières, Doctors Without Borders, Southern Africa Medical Unit (SAMU)
  98. Dr. Jamunanantha , MBBS,DTCD, C.S.
  99. Alex Jaucot, General Director, Damien Foundation Belgium
  100. Prof Mohamed F. Jeebhay, Head of Department and Director, School of Public Health and Family Medicine, University of Cape Town, South Africa
  101. Dr. Stephen John, MPH/ICHD, Executive Secretary, ADSACA, Toronto, Canada
  102. Michael Kachumi, CHAZ (Faith Based/malaria), Zambia
  103. Yvonne Kahimbura, EANNASO
  104. Adeeba Kamarulzaman, Dean, The Faculty of Medicine, University of Malaya, Malaysia
  105. Bertrand Pfouminzhouer Kampoer, Executive Director, For Impacts In Social Health (FIS), Yaounde, Cameroon
  106. Wisdom Kanyamula, Executive Director CHISA, Malawi
  107. Brian Kanyemba, HIV Research (CCM KP), South Africa
  108. Beyonce Karungi, Transeq uganda (KP), Uganda
  109. Salmaan Keshavjee MD, PhD, ScM, Director, Harvard Medical School Center for Global Health Delivery-Dubai
  110. Dr Mohammad Khaled ( Seddiq ) MD - MPH, NTP Director , Ministry of Public Health Afghanistan
  111. Professor Masood Hameed Khan, Chairman, Stop TB Pakistan (National Partnership) Secretariat 507, Kavish Crown Plaza, Main Shahra-e-Faisal, Karachi-Pakistan & Founding Vice Chancellor, Dow University of Health Sciences, Baba-e-Urdu, Road, Karachi-Pakistan
  112. Evelyn Kibuchi, Stop TB Partnership Kenya
  113. Nana Kiria, Clinical Director, NCTLD, Georgia
  114. Dr Koot Kotze, TB Proof, South Africa
  115. Kelvin Kudakwashe Makura, Programs Officer (TB & HIV), Zimbabwe Young Positives
  116. Blessina Kumar, CEO (I), Global Coalition of TB Activists (GCTA), India
  117. Dr. Dipak Kumar Biswas, Medical Coordinator, Damien Foundation Bangladesh
  118. Abdusamad Latifov, TB Projects Manager Assistant on TB prevention, STOP TB Partnership Tajikistan, Tajikistan
  119. Erica Lessem, MPH, DirectorTB/HIV Project, Treatment Action Group
  120. Evelyne Letio Unzi, NEPWU - PLHIV, South Sudan
  121. Sharon Lewin, Director, The Peter Doherty Institute for Infection and Immunity, Australia
  122. David Lewinsohn, MD, PhD, Pulmonary & CCM, Oregon Health & Science University, USA
  123. Dean Lewis, Senior Research Fellow, Centre for Health Policy Inequalities and Research , Duke University, USA
  124. Stephen Lewis, Co-Director, AIDS-Free World
  125. Miguel José Martínez Lirola, Laboratorio Provincial de Micobacterias de Almeria, Complejo Hospitalario Torrecárdenas, Servicio Andaluz de Salud, Spain
  126. Nino Lomtadze, Head of Surveillance and Strategic Planning Department, NCTLD, Georgia
  127. Leslie London, Chair of Public Health Medicine and Head of the Health and Human Rights, Programme School of Public Health and Family Medicine, University of Cape Town, South Africa
  128. Tuan Luu, Program Manager, Clinton Health Access Initiative, Vietnam
  129. Emily MacLean, MSc - McGill University, Canada
  130. Dr. Anca Macri, Lung Diseases Specialists , Marius Nasta Institute Bucharest
  131. Talent Madziva, Katswe Sistahood - Womens sector, Zimbabwe
  132. Roland Maes
  133. Steven MacGill, PLHIV CCM, Liberia
  134. Zinenani Majawa, CCM - SW/KP, Malawi
  135. James Malar, APCASO, Asia Pacific
  136. Mamello G. Makoae, LENASO (ASO/SR), Lesotho
  137. Allan Maleche, Executive Director, KELIN, Kenya
  138. Mike Mandelbaum, Chief Executive, TB Alert
  139. Daniel Marguari, Spiritia, Indonesia
  140. RD Marte, APCASO, Asia Pacific
  141. Marguerite Massinga Loembe, MSc, PhD, Senior Scientist and PMDT consultant, Centre de Recherches Médicales de Lambaréné, Gabon
  142. Ben J. Marais, Professor, Marie Bashir Institute for Infectious Diseases and Biosecurity University of Sydney, Australia
  143. Lelio Marmora, Executive Director, UNITAID
  144. Toni Martinez, Rwanda
  145. Dr K.T. MATHIVHA, Rahima Moosa Mother and Child Hospital, South Africa
  146. Dr Farai Mavhunga, Chief Medical Officer: NTLP, Directorate Special Programmes, Ministry of Health and Social Services, Namibia
  147. Kenneth Mayer, Medical Research Director, The Fenway Institute, USA
  148. Rosemary Mburu, WACI Health
  149. Igor Medvid, HPLGBT, Kyiv, Ukraine
  150. Donika Mema, MD/ Epidemiologist, National Manager of TB Program, University Hospital Shefqet Ndroqi, Tirana, Albania
  151. Dr. Sayoki G. Mfinanga, Director, Chief Research Scientist and Director Muhimbili Medical Research Centre National Institute for Medical Research, Dar Es Salaam, Tanzania
  152. Dr. Zied Mhirsi, MD, MPH, Founder of the Tunisian Center for Public Health, Tunisia
  153. Shama Mohammed, Independent Consultant
  154. David Moore, Paediatric Infectious Diseases Specialist, Chris Hani Baragwanath Academic Hospital & Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  155. Thandeka Mthombeni, CCM Watchdog, Swaziland
  156. Deborah Mukasekuru, ANSP+, Rwanda
  157. Professor Maowia M. Mukhtar, Institute of Endemic Diseases, University of Khartoum, Khartoum, Sudan
  158. Olive Mumba, EANNASO
  159. Bernard Muramira, Strive foundation, Rwanda
  160. Greysmo Mutasjobya, HDT (CCM Watchdog), Tanzania
  161. Maziko Mutemba, CCM Vice Chair, Network, Malawi
  162. Monde Muyoyeta, TB Program Director, CIDRZ, Lusaka, Zambia
  163. Venance Muzuka, Program Director, SHDEPHA+KAHAMA, Tanzania
  164. Allie Mwachande, Faith based (CCM Watchdog), Malawi
  165. Rahab Mwaniki, Advocacy Manager, KANCO
  166. Deepali Nagpal, Chartered Accountant and MDR Patient, GCTA Support Group, India
  167. Shane Naidoo, South Africa
  168. Tushar Nair, Project Officer, Global Coalition of TB Activists GCTA, India
  169. Dorothy Namutamba, ICW EA (women), Uganda
  170. Dr. Akmal Nasrat, Program Coordinator, ACREOD, Afghanistan
  171. Dr. Ruvandhi Nathavitharana, MBBS MPH, Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School & TB Proof, USA
  172. Marc Ndayiragije, EANNASO, Burundi
  173. Uwase Ndege, Youth, Rwanda
  174. Dang Ngo, Senior Regional Director, Greater Mekong, Clinton Health Access Initiative
  175. Luan Vo Nguyen Quang, Chairman, Friends for International TB Relief, Hanoi, Viet Nam
  176. Dr Nguyen Viet Nhung, STAG TB Member
  177. Zelda Nhlabatsi, Family Life Association of Swaziland, Swaziland
  178. Tom Nicholson, Executive Director, Advance Access & Delivery, Durham, North Carolina, USA
  179. Dr.Jürgen Noeske, Senior Consultant, TB Consultant
  180. Pierre-Yves Norval, Director of TeAM Technical Assistance for Management
  181. John Ntigengwa, IMBUTO Foundation, Rwanda
  182. Khuat Thi Hai Oanh, SCDI, Viet Nam
  183. Gemma Oberth - University of Cape Town - South Africa
  184. Dr. Olanrewaju Oladimeji (MD, MsPH, MPA), African Research Fellow; Human Sciences Research Council (HSRC), South Africa, Doctoral Candidate; University of KwaZulu-Natal (UKZN), South Africa
  185. Ibrahim Oleriegbe, Plan International (PR), Liberia
  186. Ifeanyi Orazulike, ICARH - KP, Nigeria
  187. Nimer Ortuño-Gutiérrezn, MD,MPH, Medical Advisor, Damien Foundation, Belgium
  188. Peter Owiti, Wote Youth Development Projects, Kenya
  189. Aaron Oxley, Executive Director, RESULTS UK
  190. Dr David Pahan, Lepra Bangladesh
  191. Dr. Madhukar Pai, Director, McGill Global Health Programs, McGill International TB Centre, Montreal, Canada
  192. Basanta Kumar Parajuli, Volunteers for Development Nepal (VFDN), Nepal
  193. Manoj Pardeshi, NCPI+, India
  194. Patricia Paredes Jodrey, MD, MSc, DrPH, Deputy Director, Technical Strategy and Quality Unit, Pharmaceuticals and Health Technologies Group, Management Sciences for Health, USA
  195. Gem Patten, Epidemiologist, Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, South Africa
  196. Antón Penas, MD, Tuberculosis Control Unit, Departament of Pneumology, University Hospital, Lucus Augusti, Lugo, Spain
  197. Edwina Pereira, Program Director-training, International Services Association, India
  198. Shrikant Peters, Public Health Registrar, University of Cape Town, South Africa
  199. Anton Pozniak, International AIDS Society
  200. Field Phiri, Group focused consultants (CCM Watchdog), Zambia
  201. Thokozile Phiri Nkhoma, Executive Director, Facilitators of Community Transformation (FACT), Lilongwe, Malawi
  202. Dr. Yogan Pillay, M.D., Department of Health, South Africa
  203. Rosa Maria Pretell Aguilar, ATBCoalition, Perú
  204. Dr Karen du Preez, Research Clinician, Cape Town, South Africa
  205. Manju Purohit, Chairperson, TB research Cell and Scientific Committee, Head and Professor, Department of Pathology. R.D. Gardi Medical College Ujjain
  206. Viktor Pylypenko, Chairman of the All-Ukrainian association of people who recover from tuberculosis "Stronger than TB"
  207. Pedro Quiñones MD, PMP, MPH, Instituto de Salud y Derechos Humanos, Peru
  208. Dr. Md.Fahmidur Rahman, MO-FTLCP, Damien Foundation - Bangladesh
  209. Allan Ragi, Executive Director, KANCO
  210. Dr. Md. Zeaur Rahim, Consultant Tuberculosis Laboratory, International Centre for Diarrhoeal Disease Research, Bangladesh
  211. Oriol Ramis, Consultant, Epirus SCC, Barcelona, Spain
  212. Dr Elizabeth Rea, Chair, Stop TB Canada, Canada
  213. Gary Reubenson, Department of Paediatrics & Child Health, University of the Witwatersrand, Johannesburg, South Africa
  214. D'Arcy Richardson, RN, PHN, CNS, MSN, TB/Public Health Consultant
  215. Teresa Rodrigo, Project Manager PII TB, Fundación Respira de SEPAR, Barcelona, Spain
  216. Sandra E. Roelofs, MSc. Former Stop TB and WHO Goodwill Ambassador, Tbilisi, Georgia
  217. Dr Chanel Rossouw, TB Proof, South Africa
  218. Mrs. Diana Rosu, Romania
  219. John Rusimbi, RBC, Rwanda
  220. Owen Ryan, Executive Director, International AIDS Society
  221. Evans Sagwa, Project Director, SIAPS Namibia, Namibia
  222. Prof. AK Salami (FWACP), Consultant Chest Physician- University of Ilorin Teaching Hospital, Ilorin, Nigeria
  223. Doris Saldaña, Lawyer, Human Rights, Instituto de Salud y Derechos Humanos, Peru
  224. Asghar Satti, APLHIV, Pakistan
  225. Dr.Bipul Chandra Sarker, Coordinator (Health), Community Health Programme, RDRS Bangladesh
  226. Dr. Mihir Ranjan Sarker, Hospital Director, Tangail TB & Leprosy Control Project, Jalchatra Hospital, Damien Foundation Bangladesh
  227. Elvi Siahaan, MAP, Indonesia
  228. Dr. Sima Samar, Chair of the Stop TB Partnership Afghanistan, Afghanistan
  229. Dr. Arumugam Sangkar
  230. Helena Schalenbourg, Project manager legacies & corporate fundraising, Damien Foundation, Belgium
  231. Marco Schito, PhD, Scientific Director, Critical Path to TB Drug Regimens
  232. Dean Schraufnagel, MD, Executive Director, Forum of International Respiratory Society
  233. Susan Selbin, Results
  234. Elizabeth Selhore, Executive Director, Sahara CFRCAR, India
  235. Cecilia Senoo, CCM women, Ghana
  236. Abdulai Sesay, TB (CCM), Sierra Leone
  237. Jae-Gook Shin, MD, PhD, Professor of Pharmacology/ Clinical Pharmacology, Director, Pharmacogenomics Research Center, Inje University College of Medicine, Republic of Korea
  238. Dr. Shivakumar, Damien Foundation India Trust, India
  239. Bhawna Singhal, Paediatrician and XDR Survivor, GCTA Suport Group, India
  240. Ignace Singirankabo, ES RICH (FBO) CCM, Rwanda
  241. Jacob Smith, MD, Infectious Diseases Fellow, Brown University and Rhode Island Hospital, Providence Rhode Island, USA
  242. Viorel Soltan, Director, Center for Health Policies and Studies (PAS Center), Chisinau, Moldova
  243. Vieng Souriyo, LaoPHA, Lao PDR
  244. Mel Spigelman, MD, President & CEO, TB Alliance & Co-chair of the Working Group on New Drugs of the Stop TB Partnership
  245. Bruno Spire, Research Director, Inserm, France
  246. Neal Stacey, TB Survivor & Founder, 2Feet4TB
  247. Dr. Karen R. Steingart, MD, MPH, Editor , Cochrane Infectious Diseases Group, Oregon, USA
  248. Rob Stevens, Independent Public Health consultant, TB REACH, the Stop TB Partnership
  249. Hamil Suleiman, ZAYEA (KP), Zanzibar
  250. Karl Technau, Senior Medical Officer, Empilweni Service and Research Unit, Rahima Moosa Mother and Child Hospital, Johannesburg, South Africa
  251. Kelly Yoana Tello Hoyos, Profesional Especilizado, Area de Proyectos Prioritarios
  252. Eloisa Teng, TB Advocate, Philippines
  253. Martha Tholanah, National Coordinator International Community of Women Living with HIV (ICW-Zimbabwe), Harare, Zimbabwe
  254. Anso Thom, Head of Communications/Spotlight Editor, Section 27, South Africa
  255. Dylan Tierney, MD MPH, Associate Physician, Division of Global Health Equity, Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, Massachusetts, USA
  256. Sandi Tjaronda Executive Director of NANASO
  257. Aseth Tjipepa, Finance Director, Project HOPE Namibia, Namibia
  258. Ms Teresa Tórtola Fernández, Metge adjunt, Servei de Microbiologia i Parasitologia, Unitat de Micobacteris, Hospital Universitari Vall d'Hebron, Spain
  259. Donald Tobaiwa, Jointed hands (CCM), TB, Zimbabwe
  260. Anete Trajman, Visitng Professor, Instituto de Medicina Social, Rio de Janeiro State University, Brazil
  261. Philippe S.K. Tshiteta, MSH Country Representative, Management Sciences for Health, D.R. Congo-Kinshasa
  262. Nestani Tukvadze, Head of Research Department, NCTLD, Georgia
  263. Moises Uamusse, Mozambican Mine Workers Association (AMIMO), Mozambique
  264. Dr Alaine Umubyeyi Nyaruhirira, MpH, PHD, Senior Laboratory Technical Advisor, Management Sciences for Health, South Africa
  265. Ibrahim Umuro, PLHIV/TB/CCM, Nigeria
  266. Maarten van Cleeff, Retired Director, Challenge TB, the Netherlands
  267. Gilles Van Cutsem, HIV/TB Adviser, Southern Africa Medical Unit, Médecins Sans Frontières / Doctors Without Borders
  268. Dr Helene-Mari van der Westhuizen, TB Proof, South Africa
  269. Armand Van Deun, MD, PhD, Senior Researcher, Mycobacteriology Unit, Institute of Tropical Medicine, Belgium
  270. Alessandra Varga, Secretariat, New Diagnostics Working Group
  271. Nandita Venkatesan, Journalist and TB Survivor, GCTA Support Group, India
  272. Prof. Jürgen Vestbo, European Respiratory Society
  273. Andrea von Delft, TB Proof, South Africa
  274. Dr Arne von Delft, living with presumed latent MDR-TB, Public Health Medicine Registrar, University of Cape Town & TB Proof, South Africa
  275. Dr Dalene von Delft, Occupational MDR-TB survivor and Chairperson of TB Proof, South Africa
  276. Dr Nils von Delft, Occupational DR-TB Survivor, TB Proof, South Africa
  277. Dr. Jiri Wallenfels, MD, National TB Surveillance Unit, Prague, Czech Republic
  278. Joshua Wamboga, Uganda Network of AIDS Service Organizations (UNASO), Uganda
  279. Prof Robin Wood (Director of the DTHF and CEO of the DTHC)
  280. Prof. Xiaolin Wei, MBBS Division of Clinical Epidemiology & Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
  281. Heather Zar, President of Pan African Thoracic Society
  282. Louie Zepeda-Teng
  283. Ntombi Zodwa Maphosa, GCTA Board Member Africa
  284. Alimuddin Zumla GCDS, Professor of Infectious Diseases and International Health, University College London, Consultant Infectious Diseases Physician, University College London Hospitals NHS Foundation Trust, London, United Kingdom
  285. Alice Zwerling, Assistant Professor, University of Ottawa, School of Epidemiology, Public Health & Preventive Medicine, Ottawa, Canada